tuftsin has been researched along with Colitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cholewinski, G; Dzierzbicka, K; Gensicka-Kowalewska, M; Siebert, A | 1 |
Barshak, I; Bashi, T; Ben-Ami Shor, D; Bizzaro, G; Blank, M; Fridkin, M; Lachnish, J; Shoenfeld, Y | 1 |
1 review(s) available for tuftsin and Colitis
Article | Year |
---|---|
Tuftsin - Properties and Analogs.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis; Cytokines; Fullerenes; Humans; Mycobacterium tuberculosis; Neoplasms; T-Lymphocytes; Tuftsin | 2017 |
1 other study(ies) available for tuftsin and Colitis
Article | Year |
---|---|
Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease.
Topics: Animals; Colitis; Cytokines; Dextran Sulfate; Disease Models, Animal; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Mice; Phosphorylcholine; Severity of Illness Index; Tuftsin | 2015 |